Press release
Meningococcal Vaccine Market is Projected to Grow at a 10.3% CAGR, Reaching US$ 10,788.0 Million by 2034 | Fact.MR Report
Meningococcal Vaccine Market
The market is driven by the high incidence of meningococcal diseases, especially meningococcal meningitis, which are highly contagious in humans or groups. The increase in cases of these diseases is driving demand for meningococcal vaccination. Increasing focus on preventive care is also generating market demand.
For More Insights into the Market, Request a Sample of this Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=9585
Country-wise Insights
The North American meningitis vaccine market is estimated to grow at a 11.1% CAGR until 2034. In 2024, the United States is expected to lead the North American meningococcal vaccine market with a 92.5% market share.
East Asia's meningococcal vaccine market is expected to grow at a 9.8% CAGR until 2034. In 2024, meningitis vaccines are expected to hold 59.1% of China's market.
The need for meningococcal vaccines will grow significantly in China, with a forecasted market value of US$ 173 million in 2024. Furthermore, the expected CAGR in the forecast period is 10.0%, which is quite high. This growth is anticipated to lead to a market value of US$ 451 million by 2034.
Category-wise Insights
The meningococcal conjugate vaccine (MCV4) segment is anticipated to contribute 41.6% market share in terms of product type in 2024. At the same time, the serogroup B meningococcal vaccine (MenB-FHpb/MenB-4C) segment is anticipated to capture 35.3% of the market, greatly improving the industry's source diversification and stability.
According to age, teenagers and young adults will account for a dominant 28.4% of the meningococcal vaccination market in 2024. Children between the ages of 2 to 12 years are expected to maintain 25.5% market share in 2024.
Competitive Landscape
The major players involved in the market for meningococcal vaccine are Incepta Pharmaceuticals Limited, Novartis International, GlaxoSmithKline plc, Merck, CSL, Baxter International, JN International Medical Corporation, Serum Institute of India, Biomed Pvt. Ltd, China National Biotec Group, Hualan Biological Engineering Inc., Walvax Biotechnology Co., Ltd., Zhifei, Pfizer Inc., GlaxoSmithKline plc., Sanofi SA, and Nuron Biotech.
The international meningococcal vaccination market is expanding rapidly and is a highly competitive industry where numerous firms are competing for market share and a strong foundation. Various factors such as price strategies, advertising campaigns, research and development, and innovative product development fuel market competition.
Owing to the high degree of fragmentation of the meningitis vaccine market and competition among the firms for market share, there is a higher focus on strategic decision-making and competitive forces. Players are investing heavily in research and development to develop new, more effective vaccines to gain a competitive edge.
To enhance the effectiveness of operation and maximize market penetration, partnerships, joint ventures, and other strategic collaborations are also being established. Product launches and other promotional campaigns are also utilized by companies to boost meningitis vaccine sales and gain a competitive edge.
Recent Developments:
In December 2023, Pfizer received the FDA approval of Penbraya, the first pentavalent meningococcal disease vaccine for people aged 10-25 years, which delivers robust protection against severe and life-threatening infection in adolescents and young adults.
The Serum Institute of India Private Limited developed MenFive, the world's first conjugate vaccine pre-qualified by the World Health Organization to guard against Africa's five leading causes of meningococcal meningitis, in July 2023.
Browse Full Report: https://www.factmr.com/report/meningococcal-vaccine-market
Segmentation of the Meningococcal Vaccine Market
By Product type :
Meningococcal Polysaccharide Vaccine (MPSV4)
Meningococcal Conjugate Vaccine (MCV4)
Serogroup B Meningococcal Vaccine (MenB-FHpb/MenB-4C)
By Age Group :
Infants (0-24 months)
Children (2-12 years)
Adolescents and young adults
Adults
By Distribution Channels :
Institutional Sales
Retail Sales
By Region :
North America
Europe
East Asia
East Asia
South Asia & Oceania
Middle East & Africa
Check out More Related Studies Published by Fact.MR:
Medical Equipment Cooling Market
https://www.factmr.com/report/medical-equipment-cooling-market
Spinal Trauma Devices Market
https://www.factmr.com/report/spinal-trauma-devices-market
Anticoagulant Reversal Drugs Market
https://www.factmr.com/report/4338/anticoagulant-reversal-drugs-market
Orthopedic Medical Imaging Systems Market
https://www.factmr.com/report/orthopedic-medical-imaging-systems-market
Contact:
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232
Email: sales@factmr.com
About Fact.MR
We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Meningococcal Vaccine Market is Projected to Grow at a 10.3% CAGR, Reaching US$ 10,788.0 Million by 2034 | Fact.MR Report here
News-ID: 3953202 • Views: …
More Releases from Fact.MR
Intelligent Transport System Market is Evaluatedto Reach USD 63.77 Billion by 20 …
Fact.MR today released its latest report on the Intelligent Transport System (ITS) Market, projecting robust growth driven by increasing urbanization, rising demand for efficient traffic management, and advancements in smart mobility technologies. Valued at USD 30.66 billion in 2024, the global market is forecasted to expand at a compound annual growth rate (CAGR) of 7.6%, reaching USD 63.77 billion by 2034. This significant growth underscores the critical role of ITS…
Digital Door Lock System Market is Growing at a CAGR of 16% by 2034 | Key Player …
Digital Door Lock System Market is valued at USD 11 billion in 2024 and is projected to expand at a compound annual growth rate (CAGR) of 16%, reaching USD 48.7 billion by 2034. This remarkable growth is driven by the increasing popularity of smart homes, which integrate advanced security features for enhanced convenience and protection. Digital door lock systems, utilizing technologies like biometrics and wireless connectivity, offer keyless entry, remote…
Electronic Access Control Systems Market is Estmated to Reach USD 32.5 Billion b …
The global electronic access control systems market is valued at USD 14.64 billion in 2023 and is projected to expand at a compound annual growth rate (CAGR) of 8.3%, reaching USD 32.5 billion by 2033. This growth is driven by the increasing need for advanced security solutions amid rising threats of terrorism, break-ins, and data breaches. Electronic access control systems, encompassing biometrics, card-based, keypad, intruder alarm, and perimeter security technologies,…
Neurology Devices Market is Estimated to Reach USD 22,335.5 Million by 2035 | Fa …
Neurology Devices Market was valued at USD 10,944.3 million in 2024 and is forecasted to expand at a CAGR of 6.7%, reaching USD 22,335.5 million by 2035. This growth reflects the increasing demand for advanced diagnostic and therapeutic tools to address neurological disorders, including Alzheimer's disease, Parkinson's disease, major depression, epilepsy, spinal cord injury, and traumatic brain injury. Neurology devices play a crucial role in diagnosing, preventing, and treating these…
More Releases for Meningococcal
Impact Of Rising Healthcare Spending On Meningococcal Vaccines: An Emerging Driv …
The Meningococcal Vaccines Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Meningococcal Vaccines Market Size and Projected Growth Rate?
The market size for meningococcal vaccines has seen rapid expansion in the past few years. The market is forecasted to increase from $3.89 billion…
Meningococcal Vaccines Market: Combating Life-Threatening Infections
In recent years, the global Meningococcal Vaccines Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on Meningococcal Vaccines Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot of business matrices including…
Meningococcal Vaccines Market
Meningococcal Vaccines Market 2022
The Meningococcal Vaccines Market is expected to grow on an unabashed note in the next decade. With a worldwide shortage of healthcare staff, the healthcare IT solutions comprising web-based staffing platforms are doing the rounds. The future scenario won't be any different. These platforms would show the gaps, i.e. actual dearth of healthcare personnel like nurse's doctors, technicians, lab workers, and clinicians, which would help the entire…
Meningococcal Vaccines Market Report Up to 2031
Visiongain has published a new report on Meningococcal Vaccines Market Report 2021-2031: Forecasts by Vaccine Type (Conjugate, Polysaccharide, Others), by End-user (Paediatric, Adult, Traveler), by Brand (Bexsero, Menactra, Menveo, Others) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Recovery Scenarios.
Download Exclusive Sample of Report @ https://www.visiongain.com/report/meningococcal-vaccines-market-2021/#download_sampe_div
Rise in prevalence of meningitis, increasing initiatives by government and regulatory authorities coupled strong funding support from non-profit organizations…
Global Meningococcal Vaccines Market Research Report
This report studies the global Meningococcal Vaccines market status and forecast, categorizes the global Meningococcal Vaccines market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report GlaxoSmithKline JN-International Medical Novartis International Sanofi Pfizer Baxter International Geographically, this report studies the top producers and…
Meningococcal Vaccines Market Growth by 2028 | GlaxoSmithKline, Polysaccharide M …
Partnerships between the private sector and public institutions have been the chief agenda of global public health initiatives. The last few years have witnessed an increase in several private-public partnerships specifically focussing on vaccine provision in developing countries. Partnerships like the International Coordinating Group on Vaccine Provision for Epidemic Meningitis Control (ICG) help magnify the vaccine outreach to remote areas of the world with the maximum need. The governments of…
